These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 83176)

  • 1. Myelin-binding antibodies in vitro. Immunoperoxidase studies with experimental allergic encephalomyelitis, anti-galactocerebroside and multiple sclerosis sera.
    Johnson AB; Bornstein MB
    Brain Res; 1978 Dec; 159(1):173-82. PubMed ID: 83176
    [No Abstract]   [Full Text] [Related]  

  • 2. Demyelination in vitro. Absorption studies demonstrate that galactocerebroside is a major target.
    Raine CS; Johnson AB; Marcus DM; Suzuki A; Bornstein MB
    J Neurol Sci; 1981 Oct; 52(1):117-31. PubMed ID: 6170737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibodies to myelin cerebrosides and their role in the pathogenesis of autoimmune demyelinating diseases (review)].
    Taranova NP; Kirchik OS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(12):1863-72. PubMed ID: 3911691
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteolipid protein antiserum does not affect CNS myelin in rat spinal cord culture.
    Mithen F; Bunge R; Agrawal H
    Brain Res; 1980 Sep; 197(2):477-83. PubMed ID: 6157451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EAE, EAN and galactocerebroside sera bind to oligodendrocytes and Schwann cells.
    Lisak RP; Saida T; Kennedy PG; Saida K; Silberberg DH; Leibowitz S
    J Neurol Sci; 1980 Nov; 48(2):287-96. PubMed ID: 7000981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 7. Myelination inhibition factor: dissociation from induction of experimental allergic encephalomyelitis.
    Kies MW; Driscoll BF; Seil FJ; Alvord EC
    Science; 1973 Feb; 179(4074):689-90. PubMed ID: 4119452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental allergic neuritis induced by sensitization with galactocerebroside.
    Saida T; Saida K; Dorfman SH; Silberberg DH; Sumner AJ; Manning MC; Lisak RP; Brown MJ
    Science; 1979 Jun; 204(4397):1103-6. PubMed ID: 451555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebroside antibody titers in antisera capable of myelination inhibition and demyelination.
    Dorfman SH; Fry JM; Silberberg DH; Grose C; Manning MC
    Brain Res; 1978 May; 147(2):410-5. PubMed ID: 656181
    [No Abstract]   [Full Text] [Related]  

  • 10. The nature of factors in chronic relapsing EAE and MS sera which induce myelinotoxicity and cellular changes in organ culture.
    Bradbury K; Suckling AJ
    Prog Clin Biol Res; 1984; 146():193-8. PubMed ID: 6201890
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergic encephalomyelitis: modification of the response by synthetic membrane structures containing bovine myelin basic protein and cerebroside.
    Brostoff SW; Powers JM
    Brain Res; 1975 Jul; 93(1):175-81. PubMed ID: 49214
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenicity of galactocerebroside in experimental allergic demyelinating diseases.
    Yonezawa T; Hasegawa M; Arizona N; Okabe H
    Acta Neuropathol Suppl; 1981; 7():162-4. PubMed ID: 6784439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.
    Kasai N; Pachner AR; Yu RK
    J Neurol Sci; 1986 Aug; 75(1):33-42. PubMed ID: 2427659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice.
    Morris-Downes MM; Smith PA; Rundle JL; Piddlesden SJ; Baker D; Pham-Dinh D; Heijmans N; Amor S
    J Neuroimmunol; 2002 Apr; 125(1-2):114-24. PubMed ID: 11960647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism in the pathogenesis of EAE induced by an MBP-specific T-cell line and monoclonal antibodies to galactocerebroside or a myelin oligodendroglial glycoprotein.
    Fierz W; Heininger K; Schaefer B; Toyka KV; Linington C; Lassmann H
    Ann N Y Acad Sci; 1988; 540():360-3. PubMed ID: 2462812
    [No Abstract]   [Full Text] [Related]  

  • 16. On a glycolipid hapten of myelin.
    Niedieck B
    Prog Allergy; 1975; 18():353-422. PubMed ID: 807919
    [No Abstract]   [Full Text] [Related]  

  • 17. The pathogenesis and therapy of multiple sclerosis is based upon the requirement of a combination of myelin antigens for autoimmune demyelination.
    Raine CS; Traugott U
    J Neuroimmunol; 1982 Jan; 2(1):83-91. PubMed ID: 6185537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG).
    Linington C; Lassmann H
    J Neuroimmunol; 1987 Dec; 17(1):61-9. PubMed ID: 2445777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a membrane surface glycoprotein associated with central nervous system myelin.
    Poduslo JF; McFarlin DE
    Brain Res; 1978 Dec; 159(1):234-8. PubMed ID: 728798
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue culture studies of demyelinating disease: a critical review.
    Seil FJ
    Ann Neurol; 1977 Oct; 2(4):345-55. PubMed ID: 617271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.